ATTENTION: Please enable Javascript in your browser for full site functionality.
Skip to navigation Skip to main content Skip to footer

Updates

SUB-TYPE: CLASS 4 CAUTION IN USE

Class 4 caution in use-Freeflex Sodium chloride 0.9%

Fresenius Kabi Limited has informed the MHRA of an error on the infusion bag packaged into the specific batches of Sodium Chloride Intravenous Infusion 0.9% Freeflex.

 

MHRA drug alert date: 21st March 2024

 

MHRA drug alert link:https://www.gov.uk/drug-device-alerts/class-4-medicines-notification-fresenius-kabi-limited-sodium-chloride-intravenous-infusion-0-dot-9-percent-freeflex-el-24-a-slash-10

 

Pip code

Product description

Supplier

Batch Numbers

Alliance do not stock

Sodium Chloride Intravenous Infusion 0.9% Freeflex.

Fresenius Kabi

13SMR091
13SMR061
13TAR011
13SLR271

 

 

This is a caution in use only we are not accepting stock returns

 

Further information

For more information or medical information queries please email Medical.Information-UK@fresenius-kabi.com or telephone +44 (0)1928533575

For stock control enquiries please contact FK.complaints-uk@fresenius-kabi.com or telephone +44 (0) 1928 533758

SUB-TYPE: FIELD SAFETY NOTICE

Field safety notice-Carboflex dressings

Field safety notice-Carboflex dressings

We have received a recall from Convatec regarding two sizes of Carboflex dressings

 

Date of recall: 19/03/24

 

PIP CODE

DESCRIPTION

SUPPLIER

AFFECTED BATCH

2527372

CARBOFLEX N/ADH S7661 8X15CM

CONVATEC VIA NWOS

3J02333
3L04810

2527380

CARBOFLEXN/ADH  S7662 15X20CM

CONVATEC LTD (WOUNDCARE)

3J00675
3J02320
3J02332
3L04811
4A00343

 

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

 

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

SUB-TYPE: CLASS 3 RECALL

Class 3 recall- Oestrogel Pump-Pack 750 micrograms/actuation Gel

Besins Healthcare (UK) Ltd has informed the MHRA that a defective pump system was detected in two batches of Oestrogel Pump-Pack 750 micrograms/actuation Gel.

 

 

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-3-medicines-recall-besins-healthcare-uk-ltd-oestrogel-pump-pack-750-micrograms-slash-actuation-gel-estradiol-el-24-a-slash-09?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=2a4a39f7-3462-4017-8038-15c956ac6096&utm_content=immediately

 

Pip code

Product description

Supplier

Batch Numbers

2171775

OESTROGEL CAN

BESINS HEALTHCARE (ALLFS)

74800

74830

 

 

Further Information

 

For medical information enquiries please contact the Besins Healthcare UK Ltd Medical Information via email besins@eu.propharmagroup.com or by calling +44 (0)1748 828 789.

For stock control enquiries please contact Besins Healthcare UK Ltd Supply Chain via email supplychain-bhuk@besins-healthcare.com.

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

SUB-TYPE: CLASS 2 RECALL

class 2 recall-Sodiofolin 50 mg/ml, solution for injection/infusion 8ml

medac GmbH (t/a medac Pharma LLP) is recalling the product for the batch specified in this notification due to particles detected during long-term stability tests.

 

 

MHRA drug alert date:12/03/24

 

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-medac-gmbh-t-slash-a-medac-pharma-llp-sodiofolin-50-mg-slash-ml-solution-for-injection-slash-infusion-folinic-acid-400mg-slash-8ml-vial-el-24-a-slash-08?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=b4b7a401-8a7a-4596-8818-f021b9fcd1d9&utm_content=immediately)

 

Pip code

Product description

Supplier

Batch Numbers

ALLIANCE DO NOT STOCK

Sodiofolin 50 mg/ml, solution for injection/infusion 8ml

medac GmbH

E230320B

 

 

Further Information

For all medical enquiries, please contact medical information at medac Pharma LLP by email to info@medacpharma.co.uk or by telephone 01786 458086

SUB-TYPE: FIELD SAFETY NOTICE

UPDATE- Field Safety Notice- Viscopaste Bandage 4948 7.5CMX6M

This is an update to the previous field safety notice first distributed 21/12/23

 

A customer response form is being circulated, if you had received any affected stock please complete and return to the address listed: QA@evolan.se

 

We have received a Recall from EVOLAN PHARMA on VISCOPASTE BANDAGE 4948 7.5CMX6M

 

Date of recall: 21st December 2023

 

MHRA FSN Link: https://www.gov.uk/drug-device-alerts/field-safety-notices-fsns-from-18-to-22-december-2023

Pip code

Product description

Supplier

Batch Numbers

0332734

VISCOPASTE BNDG 4948 7.5CMX6M

EVOLAN PHARMA (MEDICAL)

D300381

 

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

 

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

SUB-TYPE: CLASS 4 CAUTION IN USE

Class 4 Caution in use- Concerta XL tablets 18 &36mg

Orifarm UK has informed the MHRA of an error with the Patient Information Leaflet (PIL) packaged within the parallel import packs of the specific batches of Concerta XL 18mg and 36mg prolonged release tablets mentioned in this notification.

 

MHRA drug alert date: 26th February 2024

 

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-orifarm-uk-ltd-concerta-xl-18mg-and-36-mg-prolonged-release-tablets-el-24-a-slash-07?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=a2016e58-88b6-4a8d-a1aa-ce9f9fa4bb23&utm_content=immediately

 

Pip code

Product

Supplier

Affected Batches

8436313

P.I CONCERTA XL TAB 18MG

Orifarm UK

3EE35801
3EE35802
3EE36101
3EE35803
3EE36102
3FE46100
3FE46101
3GE51900

8436370

P.I CONCERTA XL TAB 36MG

Orifarm UK

3AE07102 3GE50002
3DE29500
3FE44101
3FE44102
3AE07103
3DE29201
3DE29501
3FE44103
3FE46800
3FE46801
3EE37002

 

 

This is a caution in use only we are not accepting stock returns

 

 

Further Information

For medical information and stock control queries please email jacook@Orifarm.com, or telephone 01923 204333.

SUB-TYPE: CLASS 2 RECALL

Class 2 recall- Adakveo 10mg/ml

Novartis Pharmaceuticals UK Limited is recalling Adakveo 10 mg/ml concentrate for solution for infusion, batch number SJFN5, due to the benefit-risk balance of Adakveo no longer being considered favourable by the MHRA. This is because the Phase III study (STAND) of Adakveo in sickle cell disease patients with vaso-occlusive crises did not confirm its clinical benefit. As a consequence, the conditional marketing authorisation in the UK is being revoked.

 

 

MHRA drug alert date:21/02/24

 

MHRA drug alert link:https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-novartis-pharmaceuticals-uk-limited-adakveo-10-mg-slash-ml-concentrate-for-solution-for-infusion-el-24-a-slash-06?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=5161cd08-b491-4965-a94e-03f1b56d8e4e&utm_content=immediately

 

Pip code

Product description

Supplier

Batch Numbers

ALLIANCE DO NOT STOCK

Adakveo 10 mg/ml

Novartis Pharmaceuticals UK Limited

SJFN5

 

 

Further Information

For medical information enquiries please contact Novartis Pharmaceuticals UK Limited at: https://www.novartis.com/uk-en/contact/contact-us, by email: medinfo.uk@novartis.com or via telephone: +44 1276 698370.

For stock control enquiries please contact: commercial.team@novartis.com

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

SUB-TYPE: CLASS 3 RECALL

Class 3 recall-Ramipril 1.25mg tabs

Torrent Pharma (UK) Limited is recalling certain batches of Ramipril 1.25mg tablets as a precautionary measure due to these batches having a low assay and high related substances test results after their release to the market.

 

MHRA Drug alert link: https://www.gov.uk/drug-device-alerts/class-3-medicines-recall-torrent-pharma-uk-limited-ramipril-1-dot-25mg-tablets-el-24-a-slash-05?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=37e221c3-75aa-46d3-ad81-abb2683aab40&utm_content=immediately

 

 

Pip code

Product Description

Affected Batches

1111681

RAMIPRIL TAB 1.25MG

(TORRENT PHARMA)

MG21264
MG21334
MG21335
MG221014
MG221016
MG23488
MG23489
MG23490
MG23729

6290688

 

RAMIPRIL TAB 1.25MG

(TORRENT PHARMA)

MG21264
MG21334
MG21335
MG221014
MG221016
MG23488
MG23489
MG23490
MG23729

 

Further Information

For medical information enquiries please contact APCER Life Sciences, via telephone: 0800 0885366, or email: Medinfo.Torrent@apcerls.com

For stock control enquiries please contact the Torrent Pharma (UK) Limited Customer Service & Sales Executive via telephone: 01293 574188,or email:  luke.davies@torrentpharma.co.uk  or priti.pragji@torrentpharma.co.uk

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

 

SUB-TYPE: CLASS 4 CAUTION IN USE

Class 4 caution in use-Gepretix 100mg capsules

Exeltis UK Limited has informed the MHRA regarding an inconsistency in the Patient Information Leaflet (PIL) packaged in cartons of the specified batches of Gepretix 100mg capsules.

 

MHRA drug alert date: 1st February 2024

 

MHRA drug alert link:  https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-exeltis-uk-limited-gepretix-100mg-capsules-el-24-a-slash-04#contents

 

Pip code

Product

Supplier

Affected Batches

5401419

GEPRETIX 100MG CAP

EXELTIS HEALTHCARE

LF32022A
LF32119A
LF32120A
LF33488A
LF33513A

 

 

This is a caution in use only we are not accepting stock returns

 

Further Information

For medical information enquiries please contact Uk.medinfo@exeltis.com or telephone 01494411775.

For stock control enquiries please contact uk.office@exeltis.com

SUB-TYPE: CLASS 4 CAUTION IN USE

Class 4 caution in use- Pantoprazole 40mg Gastro resistant tablets

Crescent Pharma Limited has informed the MHRA regarding an error with the European Article Number (EAN) barcode on the cartons of the above-mentioned batches of Pantoprazole 40 mg Gastro-Resistant Tablets distributed by Crescent Pharma Limited.

 

MHRA drug alert date: 30th January 2024

 

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-cadila-pharmaceuticals-uk-limited-pantoprazole-40-mg-gastro-resistant-tablets-el-24-a-slash-03?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=65c56ca6-e713-4ca4-9ffd-014847ff9cd3&utm_content=immediately

 

Pip code

Product

Supplier

Affected Batches

1159664

PANTOPRAZOLE EC TAB 40MG ALM

ALMUS PHARMACEUTICALS LTD

ET571E3001
ET571E3002
ET571E3003
ET571E3004
ET571E3005
ET571E3006
ET571E3007
ET571E3008

1123850

PANTOPRAZOLE TAB 40MG ACC

ACCORD SCHEME

ET571E3001
ET571E3002
ET571E3003
ET571E3004
ET571E3005
ET571E3006
ET571E3007
ET571E3008

 

 

This is a caution in use only we are not accepting stock returns

 

Further Information

For medical information enquiries please contact pharmacovigilance-eu@cadilapharma.com or telephone: +44 1217901596

For stock control enquiries please contact info@crescentpharma.com or telephone: 01256 772730